Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management Read more
Boehringer Ingelheim, Enara Bio sign pact to discover novel shared antigens for cancer immunotherapies Read more
ISMMS, Boehringer Ingelheim to test nintedanib for treating pulmonary fibrosis post-COVID-19 infection Read more
Bridge Biotherapeutics, Boehringer Ingelheim cancel agreement to develop BBT-877 for idiopathic pulmonary fibrosis Read more
Drug makers, BMGF pledge to strive for global access to COVID-19 diagnostics, therapeutics and vaccines Read more
SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData Read more
Boehringer Ingelheim and Click Therapeutics join hands for CT-155, digital therapeutic for schizophrenia Read more